Investing.com – eHealth, Inc. (NASDAQ:EHTH) stock jumped 17% pre-market on Tuesday after CEO Derrick A. Duke purchased 187,969 shares of common stock at $1.38 per share on Thursday. According to Form 4 filed with the U.S. Securities and Exchange Commission, the total transaction was $259,397.
Following this purchase, Duke directly owns 487,969 shares of eHealth, representing a significant stake in the $38 million market-cap company.
At the time of the insider buy, the stock was trading near its 52-week low of $1.24, down 85% over the past year.
Craig-Hallum analyst George Sutton said he was encouraged by the insider buying activity of the new CEO and noted that during a recent conference call, the CEO’s vision for EHTH’s involvement in a broader insurance market was very clear. However, Sutton continued to believe that the Medicare Advantage market faces challenges ahead. Sutton has a hold rating on the stock.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
eHealth stock soars 17% due to CEO insider buying
Investing.com – eHealth, Inc. (NASDAQ:EHTH) stock jumped 17% pre-market on Tuesday after CEO Derrick A. Duke purchased 187,969 shares of common stock at $1.38 per share on Thursday. According to Form 4 filed with the U.S. Securities and Exchange Commission, the total transaction was $259,397.
Following this purchase, Duke directly owns 487,969 shares of eHealth, representing a significant stake in the $38 million market-cap company.
At the time of the insider buy, the stock was trading near its 52-week low of $1.24, down 85% over the past year.
Craig-Hallum analyst George Sutton said he was encouraged by the insider buying activity of the new CEO and noted that during a recent conference call, the CEO’s vision for EHTH’s involvement in a broader insurance market was very clear. However, Sutton continued to believe that the Medicare Advantage market faces challenges ahead. Sutton has a hold rating on the stock.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.